PDF(Pubmed)
Abstract：
Discrimination and inequality shape women\'s experiences of drug use and in the drug trade and the impact of drug control efforts on them, with disproportionate burdens faced by poor and otherwise marginalized women. In recent years, UN member states and UN drug control and human rights entities have recognized this issue and made commitments to integrate a \'gender perspective\' into drug control policies, with \'gender\' limited to those conventionally deemed women. But the concept of gender in international law is broader, rooted in socially constructed and culturally determined norms and expectations around gender roles, sex, and sexuality. Also, drug control policies often fail to meaningfully address the specific needs and circumstances of women (inclusively defined), leaving them at risk of recurrent violations of their rights in the context of drugs. This article explores what it means to \'mainstream\' this narrower version of gender into drug control efforts, using as examples various women\'s experiences as people who use drugs, in the drug trade, and in the criminal justice system. It points to international guidelines on human rights and drug control as an important tool to ensure attention to women\'s rights in drug control policy design and implementation.
摘要：
歧视和不平等塑造了妇女吸毒和毒品交易的经历，以及药物管制工作对她们的影响，贫穷和边缘化的妇女面临不成比例的负担。近年来,联合国会员国和联合国药物管制和人权实体已经认识到这一问题，并承诺将“性别观点”纳入药物管制政策，“性别”仅限于那些传统上被认为是女性的人。但是国际法中的性别概念更广泛，植根于围绕性别角色的社会建构和文化决定的规范和期望，性别,和性。此外，药物管制政策往往无法有意义地解决妇女的具体需求和情况(包括定义)，使他们面临在毒品方面一再侵犯其权利的风险。本文探讨了将这种较窄的性别纳入药物管制工作的主流意味着什么，以各种女性作为吸毒的人的经历为例，在毒品交易中，在刑事司法系统中。它指出国际人权和药物管制准则是确保在药物管制政策设计和实施中关注妇女权利的重要工具。
